{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:31:03Z","timestamp":1776778263197,"version":"3.51.2"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS 92625"],"award-info":[{"award-number":["R01NS 92625"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS44233"],"award-info":[{"award-number":["NS44233"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 FD004789"],"award-info":[{"award-number":["R01 FD004789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54NS065736"],"award-info":[{"award-number":["U54NS065736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23NS075141"],"award-info":[{"award-number":["K23NS075141"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mayo CCaTS","award":["UL1TR000135"],"award-info":[{"award-number":["UL1TR000135"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.parkreldis.2017.12.011","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T18:41:17Z","timestamp":1513276877000},"page":"51-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Do selective serotonin reuptake inhibitors improve survival in multiple system atrophy?"],"prefix":"10.1016","volume":"48","author":[{"given":"Elizabeth A.","family":"Coon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Eric","family":"Ahlskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Silber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Fealey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo E.","family":"Benarroch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Sandroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay N.","family":"Mandrekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip A.","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2017.12.011_bib1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archneur.63.7.978","article-title":"Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy","volume":"63","author":"Glass","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cne.10329","article-title":"Serotonin inputs to inspiratory laryngeal motoneurons in the rat","volume":"451","author":"Sun","year":"2002","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0304-3940(95)11907-E","article-title":"Serotonergic cells in nucleus raphe pallidus provide tonic drive to posterior cricoarytenoid motoneurons via 5-hydroxytryptamine2 receptors in cats","volume":"197","author":"Arita","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archneur.64.2.256","article-title":"Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy","volume":"64","author":"Tada","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.20021","article-title":"Involvement of medullary serotonergic groups in multiple system atrophy","volume":"55","author":"Benarroch","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.expneurol.2012.01.008","article-title":"Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of alpha-synucleinopathy","volume":"234","author":"Ubhi","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.24983","article-title":"Maintaining glottic opening in multiple system atrophy: efficacy of serotonergic therapy","volume":"27","author":"Ozawa","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib10","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/brain\/awv274","article-title":"Clinical features and autonomic testing predict survival in multiple system atrophy","volume":"138","author":"Coon","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.12.011_bib11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/01.wnl.0000310413.04462.6a","article-title":"Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P","volume":"70","author":"Kawai","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.12.011_bib12","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awq158","article-title":"Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy","volume":"133","author":"Brown","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.12.011_bib13","first-page":"76","article-title":"Antidepressant use in persons aged 12 and over: United States, 2005-2008","volume":"76","author":"Pratt","year":"2011","journal-title":"NCHS data brief"},{"key":"10.1016\/j.parkreldis.2017.12.011_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-009-0365-z","article-title":"Cognition in multiple system atrophy: neuropsychological profile and interaction with mood","volume":"117","author":"Balas","year":"2010","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.parkreldis.2015.04.018","article-title":"Antidepressive treatments for Parkinson's disease: a systematic review and meta-analysis. Parkinsonism","volume":"21","author":"Bomasang-Layno","year":"2015","journal-title":"Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mds.21966","article-title":"Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Devos","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/08039489850139049","article-title":"Depression in idiopathic Parkinson's disease treated with citalopram: a placebo-controlled trial","volume":"52","author":"Wermuth","year":"1998","journal-title":"Nord. J. Psychiatr."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.parkreldis.2006.04.002","article-title":"Paroxetine treatment improves motor symptoms in patients with multiple system atrophy","volume":"12","author":"Friess","year":"2006","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10286-014-0249-7","article-title":"Novel therapeutic approaches in multiple system atrophy","volume":"25","author":"Palma","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib20","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/S1353-8020(11)70066-9","article-title":"Fluoxetine protects neurons against microglial activation-mediated neurotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1460-9568.2011.07933.x","article-title":"Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model","volume":"35","author":"Kohl","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5664\/jcsm.27444","article-title":"Development of central sleep apnea after maxillofacial surgery for obstructive sleep apnea","volume":"5","author":"Corcoran","year":"2009","journal-title":"J.\u00a0Clin. Sleep. Med."},{"key":"10.1016\/j.parkreldis.2017.12.011_bib23","unstructured":"ClinicalTrials.gov. Identifier: NCT01146548."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017308374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017308374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:28Z","timestamp":1761178468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017308374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":23,"alternative-id":["S1353802017308374"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.12.011","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do selective serotonin reuptake inhibitors improve survival in multiple system atrophy?","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}